IP Library Granted Patent US 11,414,453
Granted Patent B2
US 11,414,453 · App. 17/392,170 · Granted Aug 16, 2022

Compositions and methods for synthesizing 5′-capped RNAs

Inventors: Richard I. Hogrefe (San Diego, CA); Alexandre Lebedev (San Diego, CA); Anton P. McCaffrey (San Diego, CA); Dongwon Shin (San Diego, CA)
Assignee: TriLink Biotechnologies, LLC
C07H21/02A23L33/13A61K31/711A61K31/712A61K31/7115C12N15/11C12P19/34C12Y207/07
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,414,453
App. No.
17/392,170
Granted
Aug 16, 2022
Kind
B2
Abstract

Provided herein are methods and compositions for synthesizing 5′Capped RNAs wherein the initiating capped oligonucleotide primers have the general form m7 Gppp[N 2′Ome ] n [N] m wherein m7 G is N7-methylated guanosine or any guanosine analog, N is any natural, modified or unnatural nucleoside, “n” can be any integer from 0 to 4 and “m” can be an integer from 1 to 9.

Claims (18)

1. An initiating capped oligonucleotide primer comprising the following structure:

wherein:

each of B 1 through B 10 is independently a natural, modified or unnatural nucleoside base;

M is 0 or 1;

L is 0 or 1;

q 1 is 1 and each of q 2 through q 9 is independently 0 or 1;

each R 1 is independently H or methyl;

R 2 and R 3 are independently H, OH, alkyl, O-alkyl, halogen, a linker or a detectable marker;

each of X 1 through X 13 is independently O or S;

each of Y 1 through Y 13 is independently OH, SH, BH 3 , aryl, alkyl, O-alkyl or O-aryl;

each of Z 0 through Z 22 is independently O, S, NH, CH 2 , C(halogen) 2 or CH(halogen); and

each of R 4 through R 12 are independently H, OH, OMe or a detectable marker,

wherein a nucleic acid backbone of the initiating capped oligonucleotide primer comprises at least one locked nucleic acid unit.

2. The initiating capped oligonucleotide primer of claim 1 , wherein at least one of R 2 or R 4 through R 12 is a linker.

3. The initiating capped oligonucleotide primer of claim 2 , wherein the linker comprises an O-hydrocarbyl moiety.

4. The initiating capped oligonucleotide primer of claim 2 , wherein the linker is a component of a locked nucleic acid unit.

5. The initiating capped oligonucleotide primer of claim 2 , wherein R 2 is a linker.

6. The initiating capped oligonucleotide primer of claim 5 , wherein the linker is a component of a locked nucleic acid unit.

Assignments (2)
CHANGE OF NAME Recorded Sep 23, 2022
From: TRILINK BIOTECHNOLOGIES, INC.
To: TRILINK BIOTECHNOLOGIES, LLC
Reel/Frame 061534/0139 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2021
From: HOGREFE, RICHARD I.; MCCAFFREY, ANTON P.; SHIN, DONGWON
To: TRILINK BIOTECHNOLOGIES, INC.
Reel/Frame 057179/0198 →
Cited By (2)
US 12,258,369 US 12,264,175